vimarsana.com

Latest Breaking News On - Rq pcr - Page 1 : vimarsana.com

Challenges in Standardizing Use of MRD Assessment in CLL

Although minimal residual disease (MRD) has emerged as a valuable prognostic marker across several hematological malignancies, its use in chronic lymphocytic leukemia (CLL) is mostly limited to clinical trials.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.